197 related articles for article (PubMed ID: 12766064)
1. The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability.
Gillespie BW; Musch DC; Guire KE; Mills RP; Lichter PR; Janz NK; Wren PA;
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2613-20. PubMed ID: 12766064
[TBL] [Abstract][Full Text] [Related]
2. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.
Musch DC; Gillespie BW; Lichter PR; Niziol LM; Janz NK;
Ophthalmology; 2009 Feb; 116(2):200-7. PubMed ID: 19019444
[TBL] [Abstract][Full Text] [Related]
3. Visual field improvement in the collaborative initial glaucoma treatment study.
Musch DC; Gillespie BW; Palmberg PF; Spaeth G; Niziol LM; Lichter PR
Am J Ophthalmol; 2014 Jul; 158(1):96-104.e2. PubMed ID: 24727262
[TBL] [Abstract][Full Text] [Related]
4. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.
Musch DC; Gillespie BW; Niziol LM; Lichter PR; Varma R;
Ophthalmology; 2011 Sep; 118(9):1766-73. PubMed ID: 21600658
[TBL] [Abstract][Full Text] [Related]
5. Binocular Measures of Visual Acuity and Visual Field versus Binocular Approximations.
Musch DC; Niziol LM; Gillespie BW; Lichter PR; Janz NK
Ophthalmology; 2017 Jul; 124(7):1031-1038. PubMed ID: 28408039
[TBL] [Abstract][Full Text] [Related]
6. The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study.
Newman-Casey PA; Niziol LM; Gillespie BW; Janz NK; Lichter PR; Musch DC
Ophthalmology; 2020 Apr; 127(4):477-483. PubMed ID: 31932093
[TBL] [Abstract][Full Text] [Related]
7. Development of an 18-Item Measure of Symptom Burden in Patients With Glaucoma From the Collaborative Initial Glaucoma Treatment Study's Symptom and Health Problem Checklist.
Musch DC; Tarver ME; Goren MJ; Janz NK
JAMA Ophthalmol; 2017 Dec; 135(12):1345-1351. PubMed ID: 29098286
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation.
Liu Q; Saifee M; Yu Y; Ying GS; Li S; Zhong H; Gedde SJ; Han Y
Am J Ophthalmol; 2020 Aug; 216():44-54. PubMed ID: 32224104
[TBL] [Abstract][Full Text] [Related]
9. Association of Fellow Eye With Study Eye Disease Trajectories and Need for Fellow Eye Treatment in Collaborative Initial Glaucoma Treatment Study (CIGTS) Participants.
Niziol LM; Gillespie BW; Musch DC
JAMA Ophthalmol; 2018 Oct; 136(10):1149-1156. PubMed ID: 30098162
[TBL] [Abstract][Full Text] [Related]
10. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.
Lichter PR; Musch DC; Gillespie BW; Guire KE; Janz NK; Wren PA; Mills RP;
Ophthalmology; 2001 Nov; 108(11):1943-53. PubMed ID: 11713061
[TBL] [Abstract][Full Text] [Related]
11. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
Katz J
Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
[TBL] [Abstract][Full Text] [Related]
12. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, II: structure/function regression analysis in glaucoma.
Leung CK; Chong KK; Chan WM; Yiu CK; Tso MY; Woo J; Tsang MK; Tse KK; Yung WH
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3702-11. PubMed ID: 16186352
[TBL] [Abstract][Full Text] [Related]
14. Relationship between intraocular pressure and rate of visual field progression in treated glaucoma.
Rao HL; Addepalli UK; Jonnadula GB; Kumbar T; Senthil S; Garudadri CS
J Glaucoma; 2013 Dec; 22(9):719-24. PubMed ID: 22595936
[TBL] [Abstract][Full Text] [Related]
15. Converting to SITA-standard from full-threshold visual field testing in the follow-up phase of a clinical trial.
Musch DC; Gillespie BW; Motyka BM; Niziol LM; Mills RP; Lichter PR
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2755-9. PubMed ID: 16043847
[TBL] [Abstract][Full Text] [Related]
16. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
Katz J; Congdon N; Friedman DS
Arch Ophthalmol; 1999 Sep; 117(9):1137-42. PubMed ID: 10496384
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in newly diagnosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study.
Janz NK; Wren PA; Lichter PR; Musch DC; Gillespie BW; Guire KE
Ophthalmology; 2001 May; 108(5):887-97; discussion 898. PubMed ID: 11320018
[TBL] [Abstract][Full Text] [Related]
18. Using filtered forecasting techniques to determine personalized monitoring schedules for patients with open-angle glaucoma.
Schell GJ; Lavieri MS; Helm JE; Liu X; Musch DC; Van Oyen MP; Stein JD
Ophthalmology; 2014 Aug; 121(8):1539-46. PubMed ID: 24704136
[TBL] [Abstract][Full Text] [Related]
19. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.
Wilson MR; Kosoko O; Cowan CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
Am J Ophthalmol; 2002 Sep; 134(3):399-405. PubMed ID: 12208252
[TBL] [Abstract][Full Text] [Related]
20. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics.
Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
Ophthalmology; 2013 Dec; 120(12):2540-2545. PubMed ID: 24126032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
